Condition: Carpal Tunnel Syndrome (CTS) · Sponsor: FzioMed
The trial will evaluate the efficacy of DYNAVISC in subjects with a diagnosis of persistent or recurrent carpal tunnel syndrome. This is a prospective, multicenter, randomized, evaluator-blinded clinical trial. Results will be stratified based on the method used for median nerve coverage: Group 1 (standard of care surgery followed by DYNAVISC surrounding the median nerve, n=25 participants), Group 2 (standard of care surgery followed by coverage of the median nerve with a hypothenar fat pad flap, n=25
This description comes directly from the study's public registry record.
Gere diZerega, MD · 805-630-2800 · gdizerega@fziomed.com
Stephanie Cortese, MS · 8054411968 · scortese@fziomed.com
Always discuss trial participation with your own doctor first.
| UZ Leuven | Leuven, Belgium, Belgium | Recruiting |
| AZ Delta | Roeselare, Belgium, Belgium | Recruiting |
| Hospital Angelina Caron | Araçatuba, Brazil, Brazil | Recruiting |
| Azienda Ospedale Universita Padova | Padova, Italy, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06593977